This protocol is judged by an institutional review board, an independent team that evaluations any clinical trials involving humans. If a review entails a Timetable I drug, after the board approves the protocol as ethical, the researchers must submit an application for an investigational new drug (IND) quantity within the FDA.Entry to illegal medic